Swiss Biotech Day 2025

NorthX Biologics is excited to announce that we will be attending the Swiss Biotech Day 2025 on May 5-6, 2025, at the Congress Center Basel, Switzerland. This premier global biotechnology conference has grown significantly since 2021 and now attracts over 2,500 participants from more than 40 countries. The event will feature networking opportunities with senior experts from the life science industry, presentations from innovative biotech start-ups and medium-sized companies, thematic company pitching sessions, and panel discussions. Additionally, the Swiss Biotech Success Stories Awards and the Swiss Biotech Report 2025 will be highlights of the event, along with pre-scheduled one-to-one partnering meetings.

We look forward to seeing you in Basel and exploring the future of biotechnology together!

When: May 5-6, 2025
Where: Congress Center Basel, Switzerland

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

CPHI Frankfurt 2025

NorthX Biologics will be attending the CPHI Frankfurt 2025 event, which will take place from October 28-30, 2025, at the Messe Frankfurt in Germany. Come and meet our team at booth 4.1G63!

CPHI Frankfurt is a major event in the pharmaceutical industry, attracting over 62,000 attendees and 2,400 exhibitors from more than 166 countries. It offers a platform for networking, learning, and exploring the latest innovations in pharma, with over 180 expert speakers and 100 content sessions.

When: October 28-30, 2025
Where: Messe Frankfurt, Germany

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

Nordic Life Science Days 2025

NorthX Biologics will be present at the Nordic Life Science Days 2025. This event will take place October 13-14, 2025, at Svenska Mässan in Gothenburg, Sweden.

NLSDays is the premier life science event in the Nordics, offering two days of insightful discussions, networking opportunities, and showcasing the latest advancements in the industry. Attendees can connect with leading experts, industry peers, and potential partners from around the world.

This year, we’ll be hosting a lunch workshop on Monday October 13, 12.00 – 13.00:

Growing the CDMO Partnership Alongside Clinical Phase Development
Biologics developers face complex CMC hurdles—from selecting the right CDMO to managing tech transfer and timelines. This workshop highlights real-world challenges from the sponsor’s perspective and explores how the right partners can help overcome them.

Stay tuned for more information how to sign up!

When: October 13-14, 2025
Where: Svenska Mässan, Gothenburg, Sweden

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

PEGS Boston Summit 2025

NorthX Biologics is excited to join the PEGS Boston Summit 2025, happening from May 12-16, 2025, in Boston, USA.

This summit is renowned for its focus on biologics and protein engineering. Attendees can look forward to over 300 presentations, interactive seminars, and numerous networking opportunities. The event is a prime venue for engaging with industry leaders and exploring the latest advancements in drug development and biotherapeutics.

When: May 12-16, 2025
Where: Boston, MA, USA

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

International Society for Extracellular Vesicles 2025

Join us on April 24–27 as we explore the latest breakthroughs in EV research and innovation. Don’t miss our CTO Ola Tuvesson presenting a poster “Progressing bacterial-derived extracellular vesicles to clinical stage”, poster #1308.

This annual meeting is a hub for scientific exchange, collaboration, and connection — and we’re looking forward to meeting peers, partners, and pioneers shaping the future of advanced therapies.

When: April 24-27, 2025
Where: Vienna, Austria

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

Innovation for Health

NorthX Biologics will join the Innovation for Health 2025 conference. This event is set for April 3, 2025, in Rotterdam, Netherlands.

Innovation for Health is a leading event in the health and life sciences sector, bringing together over 800 key players to discuss the latest trends, foster collaborations, and showcase groundbreaking innovations

When: April 3, 2025
Where: Rotterdam, The Netherlands

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

Advanced Therapies 2025

NorthX Biologics will be present at the Advanced Therapies Congress 2025. This event is scheduled for March 18-19, 2025, at the ExCeL London.

The Advanced Therapies Congress is Europe’s largest event dedicated to cell and gene therapies, featuring over 250 speakers and 100 exhibitors. It provides a platform for networking, collaboration, and the latest advancements in the field.

When: March 18-19, 2025
Where: ExCel London, UK

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

BIO-Europe Spring

NorthX Biologics is set to attend the BIO-Europe Spring 2025 conference. Scheduled for March 17-19, 2025, in Milan, Italy, the event will also feature digital partnering sessions on March 25-26, 2025.

This premier gathering in the life sciences sector facilitates strategic alliances, networking, and the exchange of cutting-edge industry insights.

When: March 17-19, 2025
Where: Milan, Italy

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

Dutch ATMP summit

NorthX Biologics will participate in the Dutch ATMP Summit 2025, which will take place on March 12, 2025, at Corpus Leiden, The Netherlands. This year’s summit will focus on “Automation in ATMP Manufacturing,” highlighting the latest advancements and real-world applications in the field. Industry leaders will share insights on how automation is transforming the production of Advanced Therapy Medicinal Products (ATMPs).

Join us for presentations, Q&A sessions, and networking opportunities. This event is important for professionals looking to stay ahead in the evolving ATMP sector.

When: March 12, 2025
Where: Corpus Leiden, The Netherlands

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

NorthX Biologics appoints Patrick DePalma Senior Vice President of North American Business Development

Biopharmaceutical contract development and manufacturing organization (CDMO) NorthX Biologics is pleased to announce the appointment of Patrik DePalma as Senior Vice President of Business Development in North America.

With over 30 years of experience in the pharmaceutical industry, Patrick brings a wealth of expertise in Research & Development, Quality Assurance, and Business Development, particularly in the CDMO space with a focus on complex biologics and advanced therapies.

Patrick has held pivotal leadership roles at renowned organizations, including Emergent, Vigene/Charles River, and Advaxia Biologics, where he drove business growth and forged strategic partnerships. His academic credentials include a Bachelor of Science (ACS-accredited) and a Master of Science in Analytical Chemistry (LC/MS) from Clemson University.

Janet Hoogstraate, CEO NorthX Biologics comments: “I am delighted to welcome Patrick to our team as we accelerate our growth journey, particularly in new markets like North America. His impressive track record and deep industry knowledge will undoubtedly strengthen our commercial team and enhance our ability to serve clients worldwide.”

Patrick DePalma expressed his enthusiasm for joining NorthX Biologics, saying: “NorthX Biologics offers an outstanding portfolio of services, from microbial and mammalian recombinant proteins to viral products, mRNA, plasmids, cell therapy, and extracellular vesicles. The company’s reputation as a trusted partner and its commitment to its ‘Beyond CDMO’ approach make this an exciting time to join. I look forward to collaborating with the team to support our clients in delivering life-changing therapies to patients globally.”

This strategic appointment underscores NorthX Biologics’ commitment to expanding its global reach and delivering cutting-edge solutions in the biopharmaceutical industry.